ClinicalTrials.gov
public full text
Public Domain
Adebrelimab Plus S-1 for Resected Cholangiocarcinoma
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy and Safety of HAIC Combined With Lenvatinib and PD-1 Inhibitors for Advanced Intrahepatic Cholangiocarcinoma#405144
- Neoadjuvant Therapy of HAIC（GEMOX） Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors#1171459
- Clinico-immunological Characterization and Immune Tolerance Breakdown in HU-autoimmunity#1139965
- A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma#853805
- Validation of the Proteomic Profiling as a Diagnostic Test for Extra-hepatic Cholangiocarcinoma#882288
Record · ID 411411
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive